Aeglea BioTherapeutics, Inc. Gains 20.93%
Thu, Jul 06, 2023 at 07:33 PM
Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ) soared at $0.52, representing a gain of 20.9%. On Thu, Jul 06, 2023, AGLE:NASDAQ touched a New 2-Week High of $0.52. The stock got featured on our News Catalysts scanner on Fri, Jun 23, 2023 at 04:54 PM in the 'PRIVATE PLACEMENT' category. From Thu, Jun 22, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Thu, Jun 22, 2023 at $0.96 with a volume of 255M+.
About Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ)
Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.
Top 10 Gainers:
- EdtechX Holdings Acquisition Corp. (EDTX:NASDAQ), 93.83%
- Caribou Biosciences Inc. (CRBU:NASDAQ), 45.59%
- Mullen Automotive Inc. (MULN:NASDAQ), 29.02%
- Genius Sports Limited (GENI:NYSE), 25.65%
- Barnes & Noble Education, Inc. (BNED:NYSE), 25.61%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 25%
- Eco Wave Power Global AB (publ) (WAVE:NASDAQ), 23.42%
- Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ), 20.93%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 20.32%
- Myomo, Inc. (MYO:NYSEMKT), 19.37%